Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-17-000322
Accepted
2017-02-09 00:15:10
Documents
1
Effectiveness Date
2017-02-08
Registration Form
S-1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 603
  Complete submission text file 9999999995-17-000322.txt   2002
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-213671 | Film No.: 17584280
SIC: 7389 Services-Business Services, NEC